1. Home
  2. YHC vs ITRM Comparison

YHC vs ITRM Comparison

Compare YHC & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LQR House Inc.

YHC

LQR House Inc.

HOLD

Current Price

$0.92

Market Cap

21.0M

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.30

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YHC
ITRM
Founded
2021
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.0M
24.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
YHC
ITRM
Price
$0.92
$0.30
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
181.6K
398.6K
Earning Date
11-14-2025
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,103,341.00
$390,000.00
Revenue This Year
$69.97
N/A
Revenue Next Year
$403.29
$947.65
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$0.26
52 Week High
$98.00
$1.58

Technical Indicators

Market Signals
Indicator
YHC
ITRM
Relative Strength Index (RSI) 49.51 41.27
Support Level $0.80 $0.27
Resistance Level $0.95 $0.37
Average True Range (ATR) 0.07 0.03
MACD 0.00 0.00
Stochastic Oscillator 56.74 20.07

Price Performance

Historical Comparison
YHC
ITRM

About YHC LQR House Inc.

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: